Erythromycin as a prokinetic agent: risk factors

Journal of Visceral Surgery
S BerthetJ Y Mabrut

Abstract

Erythromycin (ER) is an antibiotic with prokinetic activity. This property has led to its clinical use to improve gastric emptying in patients with gastroparesis. Several papers have reported the effectiveness of ER in such patients; however few of these studies have been well-conducted methodologically with evaluation of clinical endpoints and their results are often contradictory. A benefit/risk analysis prior to prescription of ER should take into account the numerous medication interactions of this drug as well as the prevention of cardiovascular complications, most notably torsade de pointes and cardiac arrest. The aim of this paper was to provide new insights into these adverse events and allow for better-informed prescription. Risk prevention requires prescription guidelines and effective communication among surgeons, anesthesiologists and pharmacists.

References

Apr 12, 1990·The New England Journal of Medicine·J JanssensR Bouillon
Jun 1, 1983·Archives of Internal Medicine·P D KrobothR Rault
Dec 8, 1998·JAMA : the Journal of the American Medical Association·M D DriciR L Woosley
Sep 1, 1999·Journal of Pediatric Gastroenterology and Nutrition·C Di LorenzoP E Hyman
Jun 15, 2000·European Journal of Clinical Pharmacology·F De PontiN Montanaro
Jan 11, 2001·The American Journal of Gastroenterology·P KoutsoumbiE Xynos
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zeruesenay DestaD A Flockhart
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Douglas ShafferPeter Honig
Sep 5, 2002·British Journal of Clinical Pharmacology·Fabrizio De PontiNicola Montanaro
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kiyomi ItoTomoo Itoh
Nov 26, 2003·Archives of Internal Medicine·Saul N WeingartRussell S Phillips
Apr 13, 2004·Current Opinion in Critical Care·Andrew R Davies, Rinaldo Bellomo
May 7, 2004·Journal of Clinical Gastroenterology·Rohtashav Dhir, Joel E Richter
Aug 3, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hong SunLeslie Z Benet
Sep 10, 2004·The New England Journal of Medicine·Wayne A RayC Michael Stein
Apr 7, 2005·Journal of Clinical Pharmacy and Therapeutics·A Li Wan Po
May 13, 2005·European Heart Journal·Sabine M J M StrausBruno H Ch Stricker
Dec 17, 2005·Journal of the American Medical Informatics Association : JAMIA·Heleen van der SijsMarc Berg
Jul 28, 2006·British Journal of Clinical Pharmacology·Marie L De BruinArno W Hoes
Dec 5, 2006·Current Opinion in Cardiology·Prince J Kannankeril, Dan M Roden
Feb 10, 2007·The Journal of Antimicrobial Chemotherapy·Catherine V Hawkyard, Roland J Koerner
Jun 23, 2007·Journal of Clinical Pharmacology·Toshiaki OkudairaKyoichi Ohashi
Sep 11, 2007·Critical Care Medicine·Nam Q NguyenRichard H Holloway
Nov 24, 2007·La Presse médicale·Bruno CharpiatOrnella Conort
Jun 19, 2008·The Annals of Pharmacotherapy·Pierrick BedouchBenoît Allenet
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S-F Zhou
Dec 17, 2008·British Journal of Clinical Pharmacology·Emanuel RaschiFabrizio De Ponti
Jan 28, 2009·JPEN. Journal of Parenteral and Enteral Nutrition·Robin BankheadUNKNOWN A.S.P.E.N. Board of Directors
Jun 16, 2009·British Journal of Clinical Pharmacology·Heleen van der SijsTeun van Gelder
Jul 7, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D UngS Nagar

❮ Previous
Next ❯

Citations

Aug 11, 2012·Mayo Clinic Proceedings·Christopher M WittichWilliam L Lanier
Dec 14, 2011·La Presse médicale·Philippe Ducrotté, Guillaume Gourcerol
Jan 5, 2011·British Journal of Pharmacology·Peter V Dicpinigaitis
Feb 1, 2012·Acta Anaesthesiologica Scandinavica·B CharpiatB Allenet
Sep 16, 2017·Current Treatment Options in Gastroenterology·Roberto Monreal-Robles, José M Remes-Troche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.